RecallRadar
ModerateReported April 22, 2026 (10 weeks ago)

SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide

Recalled by Owen Biosciences Inc.

Drug recall

Owen Biosciences Inc.

Class II — moderate

Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Owen Biosciences Inc. has recalled SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on April 22, 2026 and was initiated on March 3, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, with approximately 2269 bottles affected. The company behind the recall is Owen Biosciences Inc., based in Baton Rouge, LA. The FDA describes the product as: “SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.”

Why was SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide recalled?

According to the FDA, the stated reason for the recall is: “Chemical contamination: Presence of benzene.”

What should you do?

If you think you may have bought SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, compare it against the product description and identifying codes (Lot# 2567200, Exp.8/1/26 Lot# 2691600, Exp.10/30/2027) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Owen Biosciences Inc. or your local health authority.

About this recall

This recall was distributed in LA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Full recall details

Status
Ongoing
Date reported
April 22, 2026
Recall started
March 3, 2026
Distributed in
LA
What was recalled
SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.
Why it was recalled (as stated by the FDA)
Chemical contamination: Presence of benzene
How to identify the affected product
Lot# 2567200, Exp.8/1/26 Lot# 2691600, Exp.10/30/2027
Amount recalled
2269 bottles

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide recalled?+

According to the FDA: Chemical contamination: Presence of benzene

How serious is this recall?+

Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

What should I do if I have SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0454-2026. Information last synced from the FDA on July 5, 2026.

Related recalls